5.32 - ASH Update #1 - Talquetamab NEJM
Plenary Session
English - December 11, 2022 19:39 - 17 minutes - 16.3 MB - ★★★★★ - 722 ratingsScience Health & Fitness Medicine medicine oncology health policy Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: 5.31 - MUST LISTEN Grand Rounds - COVID19 Updates
Next Episode: 5.33 USC Grand Rounds Hematology
Is it acceptable to take someone with myeloma who has gotten just 2 regimens and put them on a phase 1? VP says hell no.